comparemela.com
Latest Breaking News On - Tiffanym powell - Page 1 : comparemela.com
Detailed trial data confirm Wegovy heart benefit
BioPharma
Philadelphia
Pennsylvania
United-states
Denmark
American
Danish
Eli-lilly-zepbound
Amit-khera
Tiffanym-powell
University-of-texas-southwestern-medical-center
Pfizer
Boehringer-ingelheim
Semaglutide 2.4 mg (Wegovy) Reduces Cardiovascular Risk in Overweight/Obesity with CVD
Full data from the SELECT trial offer insight into the 20% relative risk reduction associated with use of semaglutide 2.4 mg in patients with overweight or obesity and preexisting cardiovascular disease at AHA 2023.
United-states
American
Tiffanym-powell
Amit-khera
Campbellp-semaglutide-wegovy
Matt-kohlmann
Pa-michael-lincoff
American-heart-association
Novo-nordisk
National-institutes-of-health
Suzanne-tomsich-department-of-cardiovascular-medicine
University-of-texas-southwestern-medical-center
vimarsana © 2020. All Rights Reserved.